Florian Heil
Impact in
- Immunology top 0.5%
- Immune Response and Inflammation
- interferon and immune responses
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Microbiology top 2%
- Antimicrobial Peptides and Activities
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- RNA Interference and Gene Delivery 2
- Glycosylation and Glycoproteins Research 1
- Oncology 4
- Co-authors
- Hiroaki Hemmi (2 shared papers)Hubertus Hochrein (2 shared papers)Stefan Bauer (2 shared papers)Hermann Wagner (2 shared papers)Grayson B. Lipford (2 shared papers)Franziska Ampenberger (2 shared papers)Shizuo Akira (2 shared papers)Carsten J. Kirschning (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)European Journal of Immunology (1 paper)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Florian Heil
11 papers receiving 4.1k citations
Florian Heil's Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 2.7k
- Microbiology 265
- Virology 180
- Cancer Research 460
- Oncology 561
Countries citing papers authored by Florian Heil
This map shows the geographic impact of Florian Heil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Heil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Heil more than expected).
Fields of papers citing papers by Florian Heil
This network shows the impact of papers produced by Florian Heil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Heil. The network helps show where Florian Heil may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Heil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 Hit paper breakdown → | 2004 | 3072 |
| 2 | Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study Hit paper breakdown → | 2012 | 460 |
| 3 | 2003 | 406 | |
| 4 | 2016 | 116 | |
| 5 | 2015 | 46 | |
| 6 | 2018 | 16 | |
| 7 | 2020 | 14 | |
| 8 | 2011 | 10 | |
| 9 | 2023 | 8 | |
| 10 | 2017 | 6 | |
| 11 | 2020 | 4 | |
| 12 | 2025 | 0 |
About Florian Heil
Florian Heil is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 12 papers that have together received 4.2k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (3 papers), Immunotherapy and Immune Responses (2 papers), RNA Interference and Gene Delivery (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Immune Response and Inflammation (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Immunology (2.7k citations), Microbiology (265 citations), Virology (180 citations), Cancer Research (460 citations) and Oncology (561 citations). Florian Heil has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Hiroaki Hemmi, Hubertus Hochrein, Stefan Bauer, Hermann Wagner, Grayson B. Lipford, Franziska Ampenberger, Shizuo Akira, Carsten J. Kirschning, Kiyoshi Takeda and Parviz Ahmad‐Nejad. Their work appears in journals such as Frontiers in Oncology, European Journal of Immunology, Clinical Cancer Research, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.